"Fight for AMX0035 Approval Moves Forward With Amylyx NDA Announcement..."

Connecting ALS

English - September 16, 2021 14:00 - 22 minutes - 41 MB - ★★★★★ - 48 ratings
Health & Fitness Society & Culture als lou gehrig health research advocacy awareness connecting Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: "Finding Ways to Reduce Caregiver Burden and Harms…"

Next Episode: "Where the Fight to Protect Access to Telehealth Goes Next…"

This week Jeremy and Jessica talk to the team at Amylyx to discuss their recent announcement that the company intends to submit a New Drug Application for AMX0035 and the path ahead to make sure the drug is available as soon as possible.

Learn more about The ALS Association’s support for the development of AMX0035 at https://www.als.org/stories-news/als-association-applauds-amylyxs-amx0035-announcement-urges-swift-fda-approval

Learn how the case of AMX0035 proves advocacy from the ALS community can impact drug development at https://www.als.org/blog/case-amx0035-proves-advocacy-als-community-can-impact-drug-development

This episode is brought to you by The ALS Association in partnership with CitizenRacecar.